1 | 1 | | BILL AS INTRODUCED H.14 |
---|
2 | 2 | | 2025 Page 1 of 4 |
---|
3 | 3 | | |
---|
4 | 4 | | |
---|
5 | 5 | | VT LEG #378483 v.7 |
---|
6 | 6 | | H.14 1 |
---|
7 | 7 | | Introduced by Representative Krasnow of South Burlington 2 |
---|
8 | 8 | | Referred to Committee on 3 |
---|
9 | 9 | | Date: 4 |
---|
10 | 10 | | Subject: Animal welfare; use of animals in product testing 5 |
---|
11 | 11 | | Statement of purpose of bill as introduced: This bill proposes to prohibit the 6 |
---|
12 | 12 | | use of animals in product testing, with some exceptions. 7 |
---|
13 | 13 | | An act relating to prohibiting the use of animals in product testing 8 |
---|
14 | 14 | | It is hereby enacted by the General Assembly of the State of Vermont: 9 |
---|
15 | 15 | | Sec. 1. 20 V.S.A. chapter 194, subchapter 5 is added to read: 10 |
---|
16 | 16 | | Subchapter 5. Use of Animals in Product Testing 11 |
---|
17 | 17 | | § 3941. PROHIBITED USE OF ANIMALS IN PRODUCT TESTING 12 |
---|
18 | 18 | | (a) As used in this section: 13 |
---|
19 | 19 | | (1) “Alternative test method or strategy” means a test method, including 14 |
---|
20 | 20 | | a new or revised method, that: 15 |
---|
21 | 21 | | (A) does not use animals; 16 |
---|
22 | 22 | | (B) provides information of equivalent or better scientific quality and 17 |
---|
23 | 23 | | relevance compared to traditional animal test methods; and 18 BILL AS INTRODUCED H.14 |
---|
24 | 24 | | 2025 Page 2 of 4 |
---|
25 | 25 | | |
---|
26 | 26 | | |
---|
27 | 27 | | VT LEG #378483 v.7 |
---|
28 | 28 | | (C) includes computational toxicology and bioinformatics, high 1 |
---|
29 | 29 | | throughput screening methods, testing categories of chemical substances, 2 |
---|
30 | 30 | | tiered testing methods, in vitro studies, and microphysiological systems. 3 |
---|
31 | 31 | | (2) “Animal” means any nonhuman vertebrate. 4 |
---|
32 | 32 | | (3) “Biomedical research” means the investigation of the biological 5 |
---|
33 | 33 | | processes and causes of disease or research conducted to increase fundamental 6 |
---|
34 | 34 | | scientific knowledge or to expand the understanding about how processes in 7 |
---|
35 | 35 | | living organisms develop and function. “Biomedical research” does not 8 |
---|
36 | 36 | | include testing done to assess the safety or efficacy of chemicals, ingredients, 9 |
---|
37 | 37 | | drugs, vaccines, product formulations, or products. 10 |
---|
38 | 38 | | (4) “Product testing facility” means an entity, institution, business 11 |
---|
39 | 39 | | partnership, corporation, association, or other legal relationship that tests 12 |
---|
40 | 40 | | chemicals, ingredients, drugs, vaccines, product formulations, or products. 13 |
---|
41 | 41 | | (5) “Traditional animal test method” means a process, procedure, or 14 |
---|
42 | 42 | | experiment using animals to obtain information on the characteristics of a 15 |
---|
43 | 43 | | chemical, ingredient, drug, vaccine, product formulation, or product and that 16 |
---|
44 | 44 | | generates information regarding the ability of the chemical, ingredient, drug, 17 |
---|
45 | 45 | | vaccine, product formulation, or product to produce a specific biological effect 18 |
---|
46 | 46 | | under specified conditions. 19 |
---|
47 | 47 | | (b)(1) A product testing facility operating in the State shall not use a 20 |
---|
48 | 48 | | traditional animal test method if a State or federal agency responsible for 21 BILL AS INTRODUCED H.14 |
---|
49 | 49 | | 2025 Page 3 of 4 |
---|
50 | 50 | | |
---|
51 | 51 | | |
---|
52 | 52 | | VT LEG #378483 v.7 |
---|
53 | 53 | | regulating the specific product or activity for which the test method is being 1 |
---|
54 | 54 | | used has either approved an alternative test method or strategy or granted a 2 |
---|
55 | 55 | | waiver exempting a product or activity from the required traditional animal test 3 |
---|
56 | 56 | | method. 4 |
---|
57 | 57 | | (2) When there is not an alternative test method or strategy or waiver 5 |
---|
58 | 58 | | available pursuant to subdivision (1) of this subsection, a product testing 6 |
---|
59 | 59 | | facility shall use a traditional animal test method using the fewest animals 7 |
---|
60 | 60 | | possible and taking precautions to reduce animal pain and stress. 8 |
---|
61 | 61 | | (3) Nothing in this section shall: 9 |
---|
62 | 62 | | (A) apply to any animal testing conducted for the purpose of 10 |
---|
63 | 63 | | biomedical research; 11 |
---|
64 | 64 | | (B) prohibit the use of any nonanimal test method or strategy for the 12 |
---|
65 | 65 | | testing of any chemical, ingredient, drug, vaccine, product formulation, or 13 |
---|
66 | 66 | | product, even if not an alternative test method or strategy; 14 |
---|
67 | 67 | | (C) prohibit the use of a traditional animal test method as required by 15 |
---|
68 | 68 | | State or federal law; or 16 |
---|
69 | 69 | | (D) prohibit the use of a traditional animal test method that complies 17 |
---|
70 | 70 | | with a written request from a State or federal agency when the agency has 18 |
---|
71 | 71 | | approved an alternative test method or strategy but also has expressly 19 |
---|
72 | 72 | | concluded that a traditional animal test method is needed to fully assess the 20 |
---|
73 | 73 | | impacts of a product or activity on the health or safety of consumers. 21 BILL AS INTRODUCED H.14 |
---|
74 | 74 | | 2025 Page 4 of 4 |
---|
75 | 75 | | |
---|
76 | 76 | | |
---|
77 | 77 | | VT LEG #378483 v.7 |
---|
78 | 78 | | (c) On or before February 1 |
---|
79 | 79 | | |
---|
80 | 80 | | of each year, all product testing facilities 1 |
---|
81 | 81 | | operating in the State shall submit a report to the Office of the Attorney 2 |
---|
82 | 82 | | General regarding any animal testing conducted under this section during the 3 |
---|
83 | 83 | | previous calendar year. Each report shall include the number and species of 4 |
---|
84 | 84 | | animal used for traditional animal test methods, the type and number of 5 |
---|
85 | 85 | | alternative test methods used, the number of waivers used, and the purpose of 6 |
---|
86 | 86 | | any traditional animal test methods, alternative test methods, and waivers. The 7 |
---|
87 | 87 | | Office of the Attorney General shall publish on its website the results of data 8 |
---|
88 | 88 | | collected from submitted reports within 90 days following receipt. 9 |
---|
89 | 89 | | (d)(1) A violation of this section is deemed to be a violation of 10 |
---|
90 | 90 | | 9 V.S.A. § 2453. 11 |
---|
91 | 91 | | (2) The Attorney General has the same authority to make rules, conduct 12 |
---|
92 | 92 | | civil investigations, enter into assurances of discontinuance, and bring civil 13 |
---|
93 | 93 | | actions, and private parties have the same rights and remedies, as provided 14 |
---|
94 | 94 | | under 9 V.S.A. chapter 63, subchapter 1. 15 |
---|
95 | 95 | | Sec. 2 EFFECTIVE DATE 16 |
---|
96 | 96 | | This act shall take effect on July 1, 2026. 17 |
---|